SCHEMBL420374

SCHEMBL420374

CCOc1cccc(O)c1OCC.COc1cnnnc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ATM Q13315 2/20 0.40
NPC1 O15118 2/20 0.40
AGTR1 P30556 1/20 0.40
MAPT P10636 6/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NEK2 P51955 1/20 0.35
IDO1 P14902 2/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TP53 P04637 3/20 0.35
LRRK2 Q5S007 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
TSHR P16473 1/20 0.35
ALDH1A1 P00352 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Hydroxy-2-Ethoxybenzene SCHEMBL5563440 0.91 TP53 (0.41) MEN1KMT2AATMNPC1AGTR1
SCHEMBL17948237 0.86 SOAT1 (0.42) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL692632 0.86 SOAT1 (0.42) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL28392669 0.83 MAPT (0.35) MEN1KMT2AATMNPC1MAPT
SCHEMBL15732774 0.81 TP53 (0.33) MEN1KMT2ANPC1MAPTIDO1
SCHEMBL692439 0.79 SOAT1 (0.43) MEN1KMT2AMAPTIDO1TP53
SCHEMBL693461 0.79 SOAT1 (0.43) MEN1KMT2AMAPTIDO1TP53
SCHEMBL29414363 0.78 L3MBTL1 (0.46) KMT2ANPC1MAPTIDO1KDM4E
SCHEMBL148974 0.78 L3MBTL1 (0.46) KMT2ANPC1MAPTIDO1KDM4E
SCHEMBL27717958 0.78 MAPT (0.37) KMT2ANPC1MAPTIDO1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11207256-B2 Method for solubilizing poorly water-soluble cosmetic agents ATHENION AG (CH) 2021-12-28 US disclosed
US-20200170915-A1 METHOD FOR SOLUBILIZING POORLY WATER-SOLUBLE COSMETIC AGENTS ATHENION AG (CH) 2020-06-04 US disclosed
CN-106456526-B Cosmetic composition for skin whitening or skin wrinkle improvement CHUNGBUK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2019-12-13 CN disclosed
EP-3421096-A1 METHOD FOR SOLUBILIZING POORLY WATER-SOLUBLE COSMETIC AGENTS Athenion AG (CH) 2019-01-02 EP disclosed
WO-2018159683-A1 OIL-IN-WATER EMULSION COSMETIC COMPOSITION 株式会社 資生堂 2018-09-07 WO disclosed
US-20150118272-A1 METHODS FOR ENHANCING COSMETIC OR DERMATOLOGICAL NOVEL COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING A DIBENZOYL METHANE DERIVATIVE BY THE ADDITION OF MODIFIED TITANIUM DIOXIDE PARTICLES DSM IP ASSETS B.V. (NL) 2015-04-30 US disclosed
EP-2121611-B1 UV-filter compounds based on alpha,beta-dihydroxyketones DSM IP ASSETS BV (NL) 2015-04-15 EP disclosed
US-8951560-B2 Isoflavone nanoparticles and use thereof DSM IP ASSETS B.V. (NL) 2015-02-10 US disclosed
US-8765967-B2 Microcapsules with UV filter activity and process for producing them DSM IP ASSETS B.V. (NE) 2014-07-01 US disclosed
EP-1959914-B1 COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMPRISING MODIFIED TITANIUM DIOXIDE PARTICLES DSM IP ASSETS BV (NL) 2014-05-21 EP disclosed
WO-2005092283-A1 COMPOSITION COMPRISING AN HDAC INHIBITOR IN COMBINATION WITH A RETINOID DSM IP ASSETS B.V. (NL) 2005-10-06 WO disclosed
WO-2005092850-A1 AMINO ACID AND PEPTIDE CONJUGATES OF ARYLALKYLIC ACIDS FOR COSMETIC USE DSM IP ASSETS B.V. (NL) 2005-10-06 WO disclosed
WO-2005080341-A1 IONIC UV-A SUNSCREENS AND COMPOSITIONS CONTAINING THEM DSM IP ASSETS B.V. (NL) 2005-09-01 WO disclosed
WO-2005053631-A1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM DSM IP ASSETS B.V. (NL) 2005-06-16 WO disclosed
US-20050019278-A1 Sunscreen compositions as well as dihydropyridines and dihydropyranes ROCHE VITAMINS AG (CH) 2005-01-27 US disclosed
EP-1494642-A1 ORGANOSILICONE DERIVATIVES OF AMINO HYDROXYBENZOPHENONES AND THEIR USE AS UV-A FILTERS IN COSMETIC PREPARATIONS DSM IP Assets B.V. (NL) 2005-01-12 EP disclosed
EP-1474098-A1 SUNSCREEN COMPOSITIONS AS WELL AS DIHYDROPYRIDINES AND DIHYDROPYRANES DSM IP Assets B.V. (NL) 2004-11-10 EP disclosed
WO-2004069216-A1 NOVEL STABILIZED CINNAMIC ESTER SUNSCREEN COMPOSITIONS DSM IP ASSETS B.V. (CH) 2004-08-19 WO disclosed
WO-2003086340-A1 ORGANOSILICONE DERIVATIVES OF AMINO HYDROXYBENZOPHENONES AND THEIR USE AS UV-A FILTERS IN COSMETIC PREPARATIONS DSM IP ASSETS B.V. (NL) 2003-10-23 WO disclosed
WO-2003068183-A1 SUNSCREEN COMPOSITIONS AS WELL AS DIHYDROPYRIDINES AND DIHYDROPYRANES DSM IP ASSETS B.V. (NL) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050019278-A1 Sunscreen compositions as well as dihydropyridines and dihydropyranes DHPS, DSG1, DHODH MEN1 494/4885KMT2A 3282/4885ATM 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.